XTRA:AFXMedical Equipment
Carl Zeiss Meditec (XTRA:AFX) Could Be 8% Undervalued On New Partnership Wins
Carl Zeiss Meditec (XTRA:AFX) is back in focus after ZEISS Medical Technology disclosed two recent partnership agreements, one centered on virtual reality glaucoma testing and another on deploying VISUMAX 800 lasers across Aier Eye Hospital’s network.
See our latest analysis for Carl Zeiss Meditec.
The recent virtual reality glaucoma collaboration and VISUMAX 800 rollout news arrives as Carl Zeiss Meditec shares trade at €27.76, with short term momentum reflected in a 7 day share price return...